← BIST
Golden Bazaar company screen

RTALB

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makina Sanayi Ticaret A.S.

2026/3
Total assets3.5B TRY
Equity3.0B TRY
Net profit-298.3M TRY
1M TRY+12.05%
1Y TRY+32.86%
Latest period read

2026/3

Golden Bazaar
Income statement82.6M TRYRevenue
Margin read30.6B TRYGross profit
Operating strength-637,412 TRYOperating profit
Cash-profit proxy-252.1M TRYFAVÖK
Debt load926.0M TRYNet debt
Balance-sheet risk934.0M TRYFinancial debt
Shareable report

Share image

One image for social sharing. If statement rows are missing, it only shows profile and market status.

GOLDEN BAZAARBIST Company Financial Report

RTALB

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makina Sanayi Ticaret A.S.

Total assets3.5B TRY
Equity3.0B TRY
F/K4.77
PD/DD0.63
Net profit-298.3M TRY

Company information

Legal nameRTA Laboratuvarlari Biyolojik Urunler Ilac ve Makina Sanayi Ticaret A.S.
SectorİMALAT
MarketBIST
CityKOCAELİ
Foundation / registry dateNot listed in the registry record
IPO dateNot listed in the official record
First trading dateNot listed in the official record
Websitewww.rtalabs.com.tr

Return intelligence

Processed date: 02 Jun 2026
1M TRY+12.05%
1Y TRY+32.86%
SAME SECTOR COMPARISON

Same sector peers

Comparison basis: Accounting group / i̇malatPeer universe: 10With market data: 10
Market date: 02 Jun 2026

Swipe horizontally to see the full peer table.

Metric
RTALBARMGDASUZUASGYOATAKPAGROTARSANAGYOAKYHOATAGY
Avg
Market cap
1.9B TRY
32.8B TRY
15.6B TRY
8.0B TRY
7.8B TRY
7.2B TRY
6.3B TRY
2.4B TRY
699.9M TRY
611.3M TRY
8.3B TRY
F/K
4.77
30.18
38.36
1.39
—
—
—
—
—
—
18.68
PD/DD
0.63
4.61
0.98
0.30
1.15
0.90
0.51
0.38
1.06
0.77
1.13
Period ratio matrix

Margin, liquidity, and profitability heatmap

Green marks stronger readings; red marks weak or riskier readings. A full historical valuation multiple matrix needs market cap and enterprise value for each period.

Ratio2025/62025/92026/3
Gross profit marginGross profit divided by revenue.+36.2%+36.7%Not calculable
EBITDA marginEBITDA divided by revenue.-16.9%-13.8%-305.4%
Net profit marginNet period profit divided by revenue.+303.8%+241.1%-361.3%
Operating profit marginOperating profit divided by revenue.-16.9%-13.8%-0.8%
Current ratioCurrent assets divided by current liabilities.2.241.901.21
Leverage ratioTotal liabilities divided by total assets.+98.8%+5.2%+15.1%
Return on equityNet period profit divided by equity.+1216.9%+17.0%-10.1%
Return on assetsNet period profit divided by total assets.+14.3%+16.1%-8.5%
Debt / equityTotal liabilities divided by equity.+8381.7%+5.5%+17.7%
Balance periods

All Balance Sheets

Current assets, non-current assets, liabilities, and equity are shown together by reporting period.

Line item2026/32025/122025/92025/6
Current assets214.5M185.3M175.2M172.9M
Non-current assets3.3B3.2B2.3B2.1B
Total assets3.5B3.4B2.5B2.2B
Current liabilities176.7M134.2M92.3M77.2M
Non-current liabilities349.1M334.7M36.9M26.3M
Total liabilities525.9M468.9M129.2M103.5M
Equity3.0B3.0B2.3B26.3M
Net debt926.0M1.1B753.6M675.4M
Cash flow periods

Cash Flow Summary

Operating, investing, and financing cash flows are shown by reporting period. Free cash flow is shown when available.

Line item2026/32025/122025/92025/6
Operating cash flow121.1M154.4M149.6M138.5M
Investing cash flow-625,77680.5M104.2M106.6M
Financing cash flow-117.1M-236.7M-255.2M-246.7M

Cash flow

Cash movements from operating, investing, and financing activities.

3 lines4 periods shown
Financial line2026/32025/122025/92025/6Last period change
Financing Cash Flow-117.1M-236.7M-255.2M-246.7M+50.54%
Operating Cash Flow121.1M154.4M149.6M138.5M-21.59%
Investing Cash Flow-625,77680.5M104.2M106.6M-100.78%

Financial trends

2024/12No data
2025/368.4B TL
2025/6-68.2B TL
2025/960.0M TL
2025/12No data
2026/382.6M TL